Login / Signup
Kayla Schwartz
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 6
Top Topics
Single Cell
Binding Protein
Hyaluronic Acid
Mesenchymal Stem Cells
Top Venues
JMIR dermatology
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Emily Eachus
,
Kayla Schwartz
,
Taha Faiz Rasul
,
Daniel Bergholz
,
Jonette Keri
,
Armen Henderson
REDCap as a Platform for Cutaneous Disease Management in Street Medicine: Descriptive Study.
JMIR dermatology
7 (2024)
Emily Eachus
,
Kayla Schwartz
,
Taha Faiz Rasul
,
Daniel Bergholz
,
Jonette Keri
,
Armen Henderson
REDCap as a Platform for Cutaneous Disease Management in Street Medicine: Descriptive Study.
JMIR dermatology
7 (2024)
Emily Eachus
,
Kayla Schwartz
,
Taha Faiz Rasul
,
Daniel Bergholz
,
Jonette Keri
,
Armen Henderson
REDCap as a Platform for Cutaneous Disease Management in Street Medicine: Descriptive Study.
JMIR dermatology
7 (2024)
Emily Eachus
,
Kayla Schwartz
,
Taha Faiz Rasul
,
Daniel Bergholz
,
Jonette Keri
,
Armen Henderson
REDCap as a Platform for Cutaneous Disease Management in Street Medicine: Descriptive Study.
JMIR dermatology
7 (2024)
Emily Eachus
,
Kayla Schwartz
,
Taha Faiz Rasul
,
Daniel Bergholz
,
Jonette Keri
,
Armen Henderson
REDCap as a Platform for Cutaneous Disease Management in Street Medicine: Descriptive Study.
JMIR dermatology
7 (2024)
Stacey L Lehman
,
Theresa Wechsler
,
Kayla Schwartz
,
Lauren E Brown
,
John A Porco
,
William G Devine
,
Nahum Sonenberg
,
Uma T Shankavaram
,
Kevin Camphausen
,
Philip J Tofilon
Inhibition of the Translation Initiation Factor eIF4A Enhances Tumor Cell Radiosensitivity.
Molecular cancer therapeutics
21 (9) (2022)